Collegium Pharmaceutical, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Collegium Pharmaceutical, Inc. (COLL) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value of $10.88 million as of 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue · last filed 2019-02-27
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $10.88M.
- 2018-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $6.92M.
- 2018-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $28.15M.
- 2018-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $35.24M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value |
|---|---|
| 2018-12-31 | $10.88M 10-K · filed 2019-02-27 |
| 2018-09-30 | $6.92M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $28.15M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $35.24M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $16.18M 10-K · filed 2018-03-07 |
| 2017-09-30 | $3.57M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $5.69M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $3.46M 10-Q · filed 2017-05-10 |
| 2016-09-30 | $14.62M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $5.34M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $12.65M 10-Q · filed 2016-05-11 |
| 2015-09-30 | $18.59M 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |